-
Arena Pharmaceuticals to Host Key Opinion Leader Event on S1P Modulation and Etrasimod in Autoimmune Diseases on January 29 in New York City
22 Jan 2018 22:25 GMT
… the event.
Additionally, Arena Pharmaceuticals' management team … other diseases including hydrocephalus, schizophrenia, neuropathic pain and fibrosis … ulcerative colitis.
About Arena Pharmaceuticals
Arena Pharmaceuticals is a biopharmaceutical company …
-
Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition
15 Oct 2024 00:38 GMT
… and LP659 were licensed from Arena Pharmaceuticals.
Lundbeck focuses on neuroscience drugs … -selling product is Rexulti, a schizophrenia and depression drug that last …
-
BMS chief Boerner says company is still open to deals after spending more than $20B on M&A last year
12 Jun 2024 17:32 GMT
… Karuna Therapeutics and its promising schizophrenia candidate KarXT. Just before the … potential launch of Karuna’s schizophrenia prospect KarXT—up for a … of billions of dollars on Arena Pharmaceuticals, Biohaven Pharma, Global Blood Therapeutics …
-
Anavex Life Sciences Announces Expansion of Leadership Team
22 May 2024 11:30 GMT
… ’s disease, Rett syndrome, schizophrenia, and other central nervous system … Intercept Pharmaceuticals, Amylin Pharmaceuticals, and Arena Pharmaceuticals. He received his BS degree … ;s disease, Rett syndrome, schizophrenia, and other central nervous system …
-
Regulatory tracker: Lilly's Retevmo secures pediatric cancer FDA nod
03 Jan 2024 17:45 GMT
… approval for its long-acting schizophrenia treatment Risvan.
Risvan is a … is approved for use in schizophrenia patients as an every-other … through its $6.7 billion Arena Pharmaceuticals acquisition. The drug rivals Bristol …
-
3 Insanely Expensive Stocks To Avoid
21 Feb 2023 21:34 GMT
… a drug (KarXT) to combat schizophrenia and psychosis associated with Alzheimer … Therapeutics
NTLA
is down 53%. Arena Pharmaceuticals
ARNA
is up 7%.
Disclosure …
-
Global Cannabinoid Derived Pharmaceutical Market Assessment worth US$ 11.2 Billion by 2030-Report by InsightAce Analytic
19 Aug 2022 11:52 GMT
… , Migraine, Multiple Sclerosis, Schizophrenia, and Others), Trends, … ., Cannabics Pharmaceuticals Inc., Arena Pharmaceuticals, One World Cannabis, Echo … • Migraine
• Multiple Sclerosis
• Schizophrenia
• Others
Global Cannabinoid Derived Pharmaceutical …
-
AbbVie: Superb 2021 Paves Way For Further Outperformance In 2022
09 Feb 2022 17:41 GMT
… for both Bipolar disorder and Schizophrenia, earned $489m last year for … are also S1P modulators like Arena Pharmaceuticals' (ARNA) Etrasimod or Bristol …
-
Global Psychiatry Deals Report 2014-2021: Access to Headline, Upfront, Milestone and Royalty Data - ResearchAndMarkets.com
08 Dec 2021 13:03 GMT
… , Obsessive compulsive disorder, Personality disorder, Schizophrenia, Sleep disorders, Insomnia, Narcolepsy, Sleep … Biotech
ARCH Personalized Medicine Initiative
Arena Pharmaceuticals
Arizona State University
Armor
Artelo …
-
The Daily Biotech Pulse: FDA Panel Review For Alkermes, Axovant Gets Rare Pediatric Disease Designation, 2 IPOs
09 Oct 2020 11:26 GMT
… )
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN)
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)
argenx SE … for the proposed indications of schizophrenia and bipolar I disorder.
The …
About
© 1995-2025